Searched for
PIRAMAL PHARMA LOSS
Ahead of Market: 10 things that will decide stock market action on WednesdaySensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. ...- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Should you buy the dip? Strategist Anand James shares his weekly stock strategyMarket expert Anand James suggests caution following recent volatility. He notes the Nifty needs to break above 24,140 for a confirmed upsw...
- Market Outlook: Rupak De’s top 3 trading stock picks for the week aheadGeopolitical tensions, rising crude oil, and a weakening rupee are fueling market volatility, according to Rupak De of LKP Securities. He n...
- Pharma, Auto, and IT: Pankaj Pandey shares sectoral insights amid global challengesPankaj Pandey shares insights on Indian sectors facing US tariffs. He sees limited impact on pharma growth but potential benefits for Jubil...
- Piramal Pharma Q3 Results: Co reports loss as CDMO slowdown drags revenuePiramal Pharma swung to a Rs 136 crore Q3 loss as revenue fell 3%, hit by CDMO destocking, weak US biopharma funding, trade uncertainty and...
- Piramal Pharma stock in focus on $80 million expansion plan for Kentucky injectables facilityPiramal Pharma Solutions, is investing $80 million to expand its Lexington facility, doubling capacity by Q1 2027 to meet growing injectabl...
- Piramal Pharma targets to double revenue in 5 yearsPiramal Pharma aims to achieve $2 billion in annual revenue with a 25% operating margin by fiscal 2030, driven by its CDMO business. The co...
- Piramal Pharma Q1 Results: Net loss narrows to Rs 89 crorePiramal Pharma Q1 Earnings: Piramal Pharma narrowed its net loss to Rs 89 crore in Q1FY25 from a net loss of Rs 99 crore in the correspondi...
- Mileen Vasudeo’ 2 stock recommendations in this marketMileen Vasudeo says: “Unless and until, Nifty breached 20,850 which was last week’s low, there is a fair chance Nifty is likely to head hig...
- Piramal Pharma's US arm faces civil suit from VetDC Inc"VetDC has alleged that it has suffered damages to the extent of USD 8.91 million approximately under various counts in this civil suit. Ve...
- Piramal Pharma posts net loss of Rs 99 crore in Q1FY24The contract research and manufacturing serivces (CDMO) revenues rose 17% YoY to Rs 898 crore led by order inflow momentum and strong execu...
- Piramal Pharma Q3 Results: Firm reports Rs 90 cr loss, gets board nod to raise up to Rs 1,050 crPiramal Pharma said while the YoY financials are not strictly comparable due to the non-inclusion of certain "non-common control transactio...
- Piramal Pharma stock rises over 3%. Here’s whyThe brokerage firm Jefferies assigned buy rating to Piramal Pharma with a target price of Rs 150, implying an upside potential of 20% from ...
- Carlyle picks up 20% stake in Piramal pharma biz for $490 mnThe 20% stake sale values Piramal’s pharma business at Rs 20,000 crore.
- Carlyle leads race for Piramal pharma stakell three have recently submitted binding offers to acquire a 20 per cent stake.
- Piramal Life lines up Rs 200 cr for new drug researchPiramal Lifesciences, the drug research company of the Piramal Group, will invest Rs 200 crore in the next two years for developing new med...
- Piramal to invest Rs 200 cr to develop new medicinesPiramal Lifesciences, the drug research company of the Piramal group, will invest Rs 200 crore in the next two years for developing new med...
Load More
